Literature DB >> 8954016

Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.

B T Teh1, F Farnebo, U Kristoffersson, B Sundelin, J Cardinal, R Axelson, A Yap, M Epstein, H Heath, D Cameron, C Larsson.   

Abstract

Hereditary hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease (OMIM 145001) that has recently been mapped to chromosomal region 1q21-q32 (HRPT2). Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome. In the first family, renal lesions were present in five out of six affected individuals, whereas HPT and JT were seen in four and two cases, respectively. In the second family, JT was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease. The possibility of the latter cosegregating as a separate autosomal dominant gene can not be ruled out. A sex-dependent penetrance of primary HPT, resulting in predominantly male-affected cases was evident in the two families. Twenty microsatellite markers in the HRPT2 region were typed, in addition to markers in the multiple endocrine neoplasia (MEN) types 1 and 2 regions at 11q13 and 10q11. The disease in these two kindreds was linked to five markers in the 1q21-q32 region (logarithm-of-odds scores: 3.2-4.2), whereas linkage to the MEN1 and MEN2 regions was excluded. Meiotic recombinations detected in affected individuals placed the locus telomeric of D1S215, thus narrowing the HRPT2 region from > 60 to approximately 34 centimorgans. Loss of heterozygosity was studied in seven renal hamartomas from two affected individuals in the first family, as well as in a jaw tumor and a parathyroid tumor from the second family. All renal hamartomas showed loss of heterozygosity at the 1q21-q32 region. The losses invariably involved the wild type allele derived from the unaffected parent, suggesting the inactivation of a tumor suppressor gene in this region.

Entities:  

Mesh:

Year:  1996        PMID: 8954016     DOI: 10.1210/jcem.81.12.8954016

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

1.  Patterns of chromosomal imbalances in parathyroid carcinomas.

Authors:  S Kytölä; F Farnebo; T Obara; J Isola; L Grimelius; L O Farnebo; K Sandelin; C Larsson
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Immunohistochemical assessment of parafibromin in mouse and human tissues.

Authors:  Andrea Porzionato; Veronica Macchi; Luisa Barzon; Giulia Masi; Maurizio Iacobone; Anna Parenti; Giorgio Palù; Raffaele De Caro
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

3.  Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.

Authors:  J-H Zhang; L M Panicker; E M Seigneur; L Lin; C D House; W Morgan; W C Chen; H Mehta; M Haj-Ali; Z-X Yu; W F Simonds
Journal:  Cell Death Differ       Date:  2010-03-26       Impact factor: 15.828

4.  [Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Authors:  O Gimm; K Lorenz; P Nguyen Thanh; U Schneyer; M Bloching; V M Howell; D J Marsh; B T Teh; U Krause; H Dralle
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

5.  Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.

Authors:  H Kanayama ; W O Lui; M Takahashi; T Naroda; D Kedra; F K Wong; Y Kuroki; Y Nakahori; C Larsson; S Kagawa; B T Teh
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

Review 6.  Familial adult renal neoplasia.

Authors:  M Takahashi; R Kahnoski; D Gross; D Nicol; B T Teh
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

Review 7.  Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Authors:  Jonathan D Wasserman; Gail E Tomlinson; Harriet Druker; Junne Kamihara; Wendy K Kohlmann; Christian P Kratz; Katherine L Nathanson; Kristian W Pajtler; Andreu Parareda; Surya P Rednam; Lisa J States; Anita Villani; Michael F Walsh; Kristin Zelley; Joshua D Schiffman
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

8.  CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.

Authors:  Cathy D Vocke; Christopher J Ricketts; Mark W Ball; Laura S Schmidt; Adam R Metwalli; Lindsay A Middelton; J Keith Killian; Javed Khan; Paul S Meltzer; William F Simonds; Maria J Merino; W Marston Linehan
Journal:  Urology       Date:  2018-11-16       Impact factor: 2.649

9.  Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q.

Authors:  M R Hobbs; A R Pole; G N Pidwirny; I B Rosen; R J Zarbo; H Coon; H Heath; M Leppert; C E Jackson
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

Review 10.  [Hereditary renal tumors: More common than expected?].

Authors:  A Agaimy; A Hartmann
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.